期刊文献+

抑癌基因OVCA1的研究进展 被引量:3

Research Advances on Tumor Suppressor Gene OVCA1
下载PDF
导出
摘要 随着肿瘤分子生物学技术及学科的发展,人们认识到癌症是一种基因疾病,肿瘤的发生发展是多种基因参与的复杂过程,包括癌基因的异常激活和肿瘤抑制基因失活。新近分离鉴定的重要的肿瘤抑制基因——卵巢癌基因1(OVCA1)在多种肿瘤中存在高频率的缺失和突变,对多种癌细胞增殖有明显的抑制作用,可能作用于肿瘤发生的早期阶段,在哺乳动物中高度保守,提示在细胞中具有重要作用;OVCA1可能具有调控细胞周期、翻译、DNA损伤及胚胎发育等生物功能,具体作用机制尚不明确;体外研究显示,OVCA1的缺失表达导致肿瘤发生可能与周期蛋白D1上调表达、P16下调表达相关,与p53基因突变可能存在相互作用;OVCA1的缺失表达与卵巢癌发生发展及预后密切相关,与宫颈癌及人乳头瘤病毒感染、乳腺癌等恶性肿瘤的关系尚在研究中。我们简要综述了OVCA1基因的国内外研究进展,为卵巢癌等恶性肿瘤进行基因水平的诊治提供理论依据。 With the development of tumor molecular biology techniques and disciplines, it is recognized that cancer is a genetic disease, tumor development is a complex process within multiple genes are involved, including abnormal activation of oncogenes and tumor suppressor gene inactivation. Recent important tumor suppressor gene isolated and identified the presence of high frequency ovarian cancer gene 1(OVCA1) deletion and mutation in a variety of tumors, for a variety of cancer cell proliferation significantly inhibited, the possible role in the early stages of tumorigenesis, highly conserved in mammals, suggesting an important role in the cell. OVCA1 may regulate the cell cycle, translation, DNA damage and embryo development, and have other biological functions, specific mechanism of action is unclear. OVCA1 vitro studies have shown that lack of expression leads to tumorigenesis may upregulate the expression of cyclin D1 and P16 reduced expression, correlating with p53 gene mutation may be present interaction. Lacking expression of OVCA1 is closely related to the occurrence, development and prognosis of ovarian cancer. Relationship between OVCA1 and malignancies such as cervical cancer and HPV infection, breast cancer is still being studied. In this paper we reviewed the research advances on tumor suppressor gene OVCA1 for providing a theoretical basis for the genetic level diagnosis and treatment of ovarian cancer and other malignant.
出处 《生物技术通讯》 CAS 2015年第2期258-263,共6页 Letters in Biotechnology
关键词 卵巢癌基因1 抑癌基因 肿瘤 ovarian cancer gene 1 tumor suppressor gene tumor
  • 引文网络
  • 相关文献

参考文献33

  • 1Shikeeva A A, Kekeeva T V, Zavalishina L , et al. Allelic imbalance in patients with non-small cell lung cancer[J]. Arkh Patol, 2013,75(2):3-8.
  • 2Zhang B, Jia W H, Matsuda K, et al. Large-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk[J]. Nat Genet, 2014,46(6):533-542.
  • 3Smardova J, Liskova K, Ravcukova B, et al. High frequency of temperature-sensitive mutants of p53 in glioblastoma[J]. Pathol Oncol Res, 2013,19(3):421-428.
  • 4Kanamori M, Sano A, Yasuda T, et al. Array-based compara- tive genomic hybridization for genomic-wide screening of DNA copy number alterations in aggressive bone tumors[J]. J Exp Clin Cancer Res, 2012,31:100.
  • 5Voeghtly L M, Mamula K, Campbell J L, et al. Molecular al- terations associated with breast cancer mortality[J]. PLoS One, 2012,7(10):e46814.
  • 6Ninomiya S, Tyybtkinoja A, Borze I, et al. Integrated analysis of gene copy number, copy neutral LOH, and microRNA pro- files in adult acute lymphoblastic leukemia[J]. Cytogenet Ge- nome Res, 2012,136(4):246-255.
  • 7张国玲,杨慧娟,许凯黎,周瑾,孙敏,秦瑞娣.卵巢癌及宫颈癌中17p13.3的杂合性丢失[J].中华肿瘤杂志,1997,19(6):401-403. 被引量:5
  • 8Phillips N J, Ziegler M R, Radford D M, et al. Allelic dele- tion on chromosome 17p13.3 in early ovarian cancer[J]. Can- cer Res, 1996,56(3):606-611.
  • 9Bruening W,Prowse A H. Expression of OVCAI,a candidate tumor suppressor,is reduced in tumors and inhibits growth of ovarian cancer cells[J]. Cancer Res, 1999,59:4973-4983.
  • 10Lazo P A. The molecular genetics of cervical carcinoma[J]. Br J Cancer, 1999,$0(12):2005-2018.

二级参考文献44

  • 1Hoff C,Mollenhauer J,Waldau B,et al. Allelic imbalance and fine mapping of the 17p13.3 subregion in sporadic breast carcinomas. Cancer Genet, 2001,299 (9) : 145-149.
  • 2Chen CM,Behringer RR. Ovcal regulates cell proliferation, embryonic development and tumorigenesis. Genes Dev, 2004,18 (3) : 320-332.
  • 3Nobukuni Y,Kohno K,Miyagawa K,et al. Gene trap mutagenesis-based forward genetic approach reveals that the tumor suppressor OVCA1 is a component of the biosynthetic pathway of diphthamide on elongation factor 2. Biol Chem,2005,280(11): 10572-10577.
  • 4Phillips N,Ziegler M,Radford D,et al. Allelic deletion on chromosome 17p13.3 in early ovarian cancer. Cancer Res,1996,56: 6O6-611.
  • 5Wendy B,Amanda HP,David C,et al. Expression of OVCA1, a candidate tumor suppress, is rescued in tumors and inhibits growth of ovarian cancer cells. Cancer Res, 1999,56 (9) : 4973 - 4983.
  • 6Capucine F,Majid T,Gaylor B,et al. HIC1 (hypermethylated in cancer 1 ) epigenetic silencing in tumors. Int J Biochem Cell Biol,2009,41 ( 1 ) : 26-33.
  • 7Chen WY,Wang DH,Yen RC,et al. Tumor suppressor HIC1 directly regulates SIRT1 to modulate P53-dependent DNA-damate responses. Ce11,2005,123(3) :437-448.
  • 8Huang J,Hu N,Alisa M,et al. High frequency allelic loss on chromosome 17p13.3 p11.1 in esophageal squamous cell carcinomas from a high incidence area in northern China. Carcinogenesis, 2000,11 (21 ) : 2019-2026.
  • 9Jonsen MR,Helin K. OVCA1 emerging as a bona fide tumor suppressor. Genes Dev, 2004,18 (3) : 245-248.
  • 10Schuhz DC, Vanderveer L, Berman DB, et al. Identification of two candidate tumor suppresser genes on chromosome 17P13.3. Cancer Res, 1996,56(9) : 1997-2002.

共引文献8

同被引文献14

引证文献3

二级引证文献10

;
使用帮助 返回顶部